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Background: MRI brain changes in Parkinson’s disease (PD) are controversial.
Objectives: We aimed to describe structural and functional changes in PD.
Methods: Sixty-six patients with PD (57.94 ±  10.25  years) diagnosed according to 
the UK Brain Bank criteria were included. We performed a whole brain analysis using 
voxel-based morphometry (VBM–SPM 8 software), cortical thickness (CT) using CIVET, 
and resting-state fMRI using the Neuroimaging Analysis Kit software to compare patients 
and controls. For VBM and CT we classified subjects into three groups according to 
disease severity: mild PD [Hoehn and Yahr scale (HY) 1–1.5], moderate PD (HY 2–2.5), 
and severe PD (HY 3–5).
results: We observed gray matter atrophy in the insula and inferior frontal gyrus in the 
moderate PD and in the insula, frontal gyrus, putamen, cingulated, and paracingulate 
gyri in the severe groups. In the CT analysis, in mild PD, cortical thinning was restricted to 
the superior temporal gyrus, gyrus rectus, and olfactory cortex; in the moderate group, 
the postcentral gyrus, supplementary motor area, and inferior frontal gyrus were also 
affected; in the severe PD, areas such as the precentral and postentral gyrus, temporal 
pole, fusiform, and occipital gyrus had reduced cortical thinning. We observed altered 
connectivity at the default mode, visual, sensorimotor, and cerebellar networks.
conclusion: Subjects with mild symptoms already have cortical involvement; however, 
further cerebral involvement seems to follow Braak’s proposed mechanism. Similar 
regions are affected both structurally and functionally. We believe the combination of 
different MRI techniques may be useful in evaluating progressive brain involvement and 
they may eventually be used as surrogate markers of disease progression.
Keywords: Parkinson’s disease, neuroimaging, cortical thickness, functional Mri, voxel-based morphometry
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unknown	 etiology,	MRI-based	 studies	 are	 important	 to	 better	
understand	disease	physiopathology.




two	 studies	 evaluated	 disease	 progression	 as	 measured	 by	 the	
Hoehn	and	Yahr	 scale	 (HY),	and	 their	outcomes	differed.	One	
revealed	minimal	statistically	significant	GM	reduction	(4),	while	
the	other	described	atrophy	in	olfactory-related	regions	(5).
Cortical	 thickness	 (CT)	analysis	 is	needed	 to	assess	 cortical	
surface	properties	(6)	for	it	allows	subvoxel	precision,	as	thick-
ness	values	are	assigned	to	 individual	vertices	(7).	CT	is	useful	
to	 investigate	 subtle	cortical	 changes	 in	 the	brain	 (8).	Previous	




tivity	 (FC)	 in	spatially	distinctive	regions	 (13).	 rs-fMRI	studies	









Decreased	 FC	 in	 a	 circuit	 connecting	 posterior	 putamen	with	
the	 inferior	parietal	cortex	as	well	as	an	 increased	FC	between	
subthalamic	nuclei	and	cortical	motor	areas	were	also	described,	






thinning	 in	 lateral	occipital,	parietal	 and	 temporal,	 frontal	 and	
premotor	regions.
Cortical	 thickness	 measure	 is	 a	 valuable	 tool	 for	 it	 allows	
subvoxel	 precision	 because	 thickness	 values	 are	 assigned	 to	
individual	vertices	instead	of	voxels	(7,	9).
Despite	 the	 progress	 obtained	 in	 the	 last	 30  years	 trying	 to	
comprehend	PD	pathophysiology,	several	questions	remain.









of	 biomarkers	 for	 disease	 diagnosis	 in	 premotor	 stages	 and	
differential	 diagnosis	 with	 other	 neurodegenerative	 causes	 of	
parkinsonism.	Thus,	our	purpose	was	to	systematically	evaluate	
patients	 with	 PD	 from	 clinical	 and	 neuroimaging	 data	 using	
rs-fMRI	 and	CT	analyzes.	However,	 our	 focus	was	 to	 generate	
hypotheses	based	 in	 this	preliminary	 study,	 and	 a	 longitudinal	
study	 is	already	under	way	 in	order	 to	confirm	the	findings	 in	
this	paper.
MaTerials anD MeThODs
Cross-sectional	 study	 was	 conducted	 at	 the	 Neuroimaging	
Laboratory—Unicamp	 University	 Hospital	 and	 McConnel	
Brain	 Imaging	Center—Montreal	Neurological	 Institute	 (MNI)	
(McGill	 University).	 The	 State	 University	 of	 Campinas	 Ethics	





Sixty-six	 patients	 (57.94  ±  10.25  years)	 (43	 men)	 older	 than	
30  years	 with	 PD,	 diagnosed	 according	 to	 the	UK	 Parkinson’s	
Disease	 Society	 Brain	 Bank	 criteria	 (19)	 were	 consecutively	
recruited	 from	 the	 Movement	 Disorders	 Outpatient	 Clinic	 of	




















patients	 were	 excluded	 from	 the	 CT	 analysis	 due	 to	 excessive	
TaBle 1 | Demographic data from all Parkinson’s disease (PD) patients, mild PD, moderate PD, and severe PD.
all PD Mild PD Moderate PD severe PD
clinical data Mean sD Mean sD Mean sD Mean sD
Age 59.33 9.8 59.31 9.60 58.5 10.69 62.07 8.4
Education 6.9 4.7 8.05 4.30 7.05 5.01 4.84 3.3
Unified Parkinson’s Disease Rating Scale (UPDRS) 35.74 18.47 20.94 8.86 34 13.38 63.21 17.15
UPDRS-III 16.93 8.23 10.88 78 16.2 5.95 28.35 8.88
Hoehn and Yahr scale 2.8 1.26 1.25 0.25 2.57 0.3 4.42 0.51
Scales for Outcomes in Parkinson’s Disease—Cognition (SCOPA-COG) 19.24 6.8 21.66 3.77 19.69 7.18 13.28 7.15
SCOPA-CP 3.6 7.8 1.55 1.72 2.77 2.37 10.07 18.63
NMSS 69.57 48.19 42.72 34.97 71.61 46.95 96.53 52.43
SCHWAB (%) 73 22 88 8 76 15 34 22
Time of disease 7 6.43 2.5 4.08 7 6.62 12.14 5.31
Medication 5.4 5.7 2.5 1.9 3 2.6 9.5 6.8
3
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	(1)		 Echo-planar	 imaging	 sequences	 of	 6  min	 with	 iso-
tropic	voxel	of	 3 mm ×  3 mm ×  3 mm,	no	gap,	 39	 slices,	
FOV = 240 mm × 240 mm,	TE = 30 ms,	TR = 2000 ms,	flip	
angle = 90°,	and	180	volumes	(dynamics),	in	a	6-min	scan;
	(2)		 Volumetric	 (3D)	 T1	 WI,	 acquired	 in	 the	 sagittal	 plane	




We	used	 the	VBM8	 toolbox	 of	 the	 statistical	 parametric	map-
ping	 (SPM8)1	 and	 the	Diffeomorphic	 Anatomical	 Registration	
Exponentiated	Lie	Algebra	(Dartel)	software	on	Matlab	R2012b	
platform	to	process	and	analyze	the	images.	VBM	allows	a	voxel-
wise	 comparison	of	 local	GM	differences	between	 two	groups.	
VBM	procedure	involves	the	segmentation	of	the	original	struc-
tural	MRI	 images	 in	native	 space	 in	GM,	white	matter	 (WM),	
and	cerebrospinal	fluid	(CSF)	tissues,	followed	by	GM	and	WM	
images	normalization	to	templates	in	stereotactic	space	to	acquire	
optimized	 normalization	 parameters,	 which	 are	 applied	 to	 the	
raw	images.	GM	images	were	smoothed	using	an	8-mm	full	width	
at	 half	maximum	 (FWHM)	 isotropic	Gaussian	 kernel.	 Finally,	
we	employed	a	general	 linear	model	(GLM),	using	age	and	sex	
as	 covariates.	We	 obtained	 the	 results	 showing	 regions	 of	GM	
concentration	 with	 significant	 differences	 between	 the	 groups	






HC	 (severe	 PD	 versus	 HC).	The	 results	 were	 displayed	 using	
SPM8	and	xjView	(Human	Neuroimaging	Lab,	Baylor	College	of	
Medicine,	Houston,	TX,	USA).	We	assessed	group	comparisons	
























ate	 (n =  21),	 and	 severe	 PD	 (n =  11)	 and	 compared	 them	 to	
HC.	Statistical	analysis	was	performed	 in	Matlab	(R2008b,	The	
Mathworks,	Natick,	MA,	USA),	using	the	SurfStat	toolbox.3	We	
performed	 a	GLM	 to	 describe	CT	 as	 a	 combination	 of	 demo-
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rs-fMri analysis










The	 transformations	 fMRI-to-T1	 and	 T1-to-stereotaxic	 were	




a	 6-mm	 isotropic	Gaussian	blurring	 kernel.	A	more	detailed	





so-called	 stable	 clusters.	 BASC	 is	 first	 applied	 on	 individual	
fMRI	time	series,	and	applying	a	Circular	Block	Bootstrap	to	
fMRI	 time	 series	 derives	 replications	 of	 clustering.	 A	 stabil-













Statistical	 analysis	 was	 performed	 in	 Matlab	 (R2008b,	 The	
Mathworks,	Natick,	MA,	USA).	We	performed	a	GLM	to	describe	














Mild	 PD	 (n =  14)	 versus	HC:	 there	was	 no	GM	 reduction	 in	
any	 region	 (FWE	p <  0.05)	 (Figure  1;	Table  2).	Moderate	PD	
(n = 31)	versus	HC:	VBM	detected	GM	loss	in	the	left	insula	and	
left	inferior	frontal	gyrus,	opercular	part	(FWE	p < 0.05).	Severe	
PD	 (n =  16)	 versus	HC:	 we	 observed	GM	 atrophy	 in	 the	 left	
insula,	left	inferior	frontal	gyrus	(opercular	part),	left	putamen,	
left	and	right	medial	superior	frontal	gyrus,	left	and	right	anterior	












rectus,	 right	 temporal	 pole,	 right	 fusiform	 gyrus,	 right	middle	


























One	 region	 with	 decreased	 CT	 in	 mild	 PD	 was	 the	 left	
olfactory	 cortex,	 which	 receives	 sensory	 information	 from	 the	
FigUre 1 | (a,B) show areas with atrophy in moderate PD and severe PD patients when compared to healthy controls (HC), p < 0.05 FEW, (c–e) show area with 
cortical thinking in mild PD, moderate PD, and severe PD, respectively, when compared to HC p < 0.5, Random Fields Theory.
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ing	 fashion	 (31).	 In	 stages	 1	 and	 2,	 it	 is	 essentially	 restricted	
to	 the	 medulla	 oblongata.	 In	 stages	 3	 and	 4,	 the	 involvement	




α-synuclein	 is	 a	 prion-like	 protein	 and	 that	PD	 is	 a	 prion-like	




Considering	 our	 findings,	 even	 patients	 with	 mild	 motor	
symptoms,	already	have	cortical	involvement	(possibly	stage	4/5),	
while	we	did	not	observe	significant	atrophy	in	the	brainstem.	We	
believe	 this	 is	due	 to	a	 compensatory	mechanism	of	 the	brain,	
where	brain	alterations	are	already	present	but	 there	 is	 still	no	
clinical	symptoms.
The	 further	 progression	 seems	 to	 follow	 the	 previously	
described	 pattern.	 It	 is	 worth	 mentioning,	 nevertheless,	 that	
while	the	Braak’s	stage	takes	LB	depositions	into	consideration,	
imaging	 analyses	 are	mostly	 concerned	with	GM	 loss.	Hence,	
some	 of	 the	 differences	 in	 the	 results	may	 reflect	 the	 variable	
FigUre 2 | reduced functional connectivity (Fc) within visual (a), 
sensorimotor (B), DMn (c), and cerebellum networks (D) in PD 
patients when compared to controls. The areas in yellow have reduced 
FC with areas in blue in PD patients compared to controls at p level 0.05.
TaBle 2 | areas with reduced cortical thickness (cT) on the left and gM atrophy on the right of mild Parkinson’s disease (PD) versus healthy controls 
(hc), moderate PD versus hc and severe PD versus hc (p < 0.05).
cT Voxel-based morphometry
coordinates (x y z) areas p [random fields Theory (rFT)] coordinates (x y z) areas p (rFT)
Mild PD
−48 −11 0 L superior Temporal Gyrus <0.05 – – –
−9 31 −21 Gyrus rectus <0.05 – – –
−21 9 −18 L superior frontal gyrus <0.05 – – –
−16 6 −16 L olfactory cortex <0.05 – – –
55 −16 46 R post central gyrus <0.05 – – –
Moderate PD
14 1 69 Supplementary motor area (SMA) <0.05 −30 14 9 L insula <0.05
53 25 9 Inferior frontal gyrus <0.05 −30 14 9 L inferior frontal gyrus <0.05
16 0 71 R superior frontal Gyrus <0.05
severe PD
−41 21 9 L inferior frontal gyrus <0.05 −35 14 3 L insula <0.05
−64 -12 17 L postcentral gyrus <0.05 −35 14 3 L inferior frontal gyrus <0.05
35 −10 −38 Fusiform gyrus <0.05 −35 14 3 L putamen <0.05
−29 −15 70 L precentral gyrus <0.05 0 41 25 R superior frontal gyrus <0.05
−9 −1 70 L SMA <0.05 0 41 25 Anterior cingulum <0.05
−14 −12 67 L superior frontal gyrus <0.05 0 33 36 L superior frontal gyrus <0.05
−7 −11 71 Paracentral lobule <0.05 – – –
51 4- 34 R medial temporal gyrus <0.05 – – –
25 14 −40 R superior temporal gyrus <0.05 – – –
6
Guimarães et al. Neuroimaging Abnormalities in Parkinson’s Disease
Frontiers in Neurology | www.frontiersin.org January 2017 | Volume 7 | Article 243
under	 study,	 and	 its	measurement	 and	 not	 the	 validity	 of	 the	
findings.	VBM	is	also	not	a	particular	sensitive	tool	for	posterior	
fossa	analysis,	and	the	presence	of	LB	does	not	necessarily	imply	
measurable	 cortical	 volume	 change.	 Moreover,	 previous	 stud-
ies	 suggested	 that	 synaptic	 dysfunction	 can	 occur	without	 the	
presence	of	Lewy	bodies	per  se	 and	 that	using	 the	presence	of	
LB	to	measure	pathological	progression	might	not	be	enough	to	
predict	the	spread	of	disease	(34).
Nevertheless,	 the	 importance	 of	 these	 findings	 is	 clear.	
Pathology	 is	 far	 advanced	 throughout	 the	 brain	when	patients	

















clinical	 manifestations	 worsens.	 Previous	 longitudinal	 studies	
using	 different	 imaging	 analysis	 have	 suggested	 that	 striatal	
atrophy	occurs	earlier	in	the	disease	process,	while	cortical	GM	
loss	 is	 restricted	 to	 later	 stages,	 reduced	 overall	 gyrification,	
and	 bilaterally	 in	 the	 inferior	 parietal,	 postcentral,	 precentral,	
superior	frontal,	and	supramarginal	areas	was	present	in	patients	









TaBle 3 | areas with reduced functional connectivity in Parkinson’s disease patients when compared to healthy controls within clusters (p < 0.05).
cluster coordinate (x y z) networks areas with altered connectivity p-Value
16 −6 58 −2 Visual Parhippocampal gyrus <0.05
Lingual gyrus <0.05
Occipital pole <0.05
Superior parietal lobule <0.05
Precentral gyrus <0.05
Supramarginal gyrus <0.05
38 −3 10 34 Sensorimotor Thalamus <0.05
Insula <0.05
Superior temporal gyrus <0.05
Precentral gyrus <0.05
Inferior frontal gyrus <0.05









Superior frontal gyrus <0.05
Superior temporal gyrus <0.05
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and	 a	 longitudinal	 approach,	 taking	 age	 of	 onset	 and	 possibly	
clinical	subtypes	is	the	next	step	in	this	exploratory	study.
Functional	 connectivity	 was	 decreased	 within	 visual,	 sen-






















analysis	 that	 there	 is	widespread	decreased	FC	 in	PD,	and	 this	
correlates	with	 the	 regions	 in	which	we	 observed	 atrophy	 and	
decreased	 CT	 in	 our	 structural	 analysis.	 Different	 patterns	 of	
reduced	 connectivity	 may	 explain	 differences	 in	 clinical	 pres-
entation	within	patients	with	PD,	 such	as	dyskinesias	 (46)	and	
behavioral	differences	(47).	In	the	future,	we	may	be	able	to	study	





In	 summary,	 we	 used	 validated,	 complementary,	 and	 well-
documented	 techniques	 to	 assess	 brain	 alterations	 in	 PD.	We	
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confirmed	that	subjects	with	mild	symptoms	already	have	corti-
cal	involvement	and	similar	regions	are	affected	both	structurally	
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